Assisting talented Australian entrepreneurs to build outstanding biomedical technology companies.
At Macquarie BioVentures we are looking to invest facilities & funds in companies
in the biotech and biomedical fields which are on the road to, or have the following
- World-leading technology with a strategy for patent protection
- An experienced
management team, or an entrepreneur capable of building such a team
products with large international market potential
- A business plan
- An attractive potential for capital growth
- Articulation of a future potential exit strategy,
such as an IPO, trade sale or licensing deal
We welcome expressions of interest
from those in the life sciences industry and academic research institutions, and
we take every application seriously.
to apply to Macquarie BioVentures.
Categories of Investment
Early seed funding
Often the best ideas and technological breakthroughs have their origins in research
institutions such as universities. The combination of placement in the Macquarie
BioVentures technology park and the opportunity for seed-stage funding is a unique
offering, unmatched in Australia. Business mentoring can be provided, and business
plans developed with the help of the technology park’s experienced managers and
mentors. Seed-stage investment is typically smaller, but considerable assistance
is available to help take the company to the next level.
Companies that have developed a business plan and taken strong steps towards protection
of their intellectual property. Usually these companies have established a management
team and have a clear idea of their potential exit strategies. Macquarie BioVentures
invests in start-ups that have their own premises, or are seeking new facilities.
Major spin-off entities or joint ventures from established companies are an attractive
option for rapidly developing shareholder value from companies that have either
a suite of technologies, or new applications of an existing technology. Often the
resources, both facilities and funds, require a fresh approach to avoid conflicts
with the mainstream business activities of the company.